92 related articles for article (PubMed ID: 15643194)
1. Human kallikrein-2 gene polymorphism is associated with the occurrence of prostate cancer.
Chiang CH; Hong CJ; Chang YH; Chang LS; Chen KK
J Urol; 2005 Feb; 173(2):429-32. PubMed ID: 15643194
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection.
Nam RK; Zhang WW; Trachtenberg J; Diamandis E; Toi A; Emami M; Ho M; Sweet J; Evans A; Jewett MA; Narod SA
J Clin Oncol; 2003 Jun; 21(12):2312-9. PubMed ID: 12805332
[TBL] [Abstract][Full Text] [Related]
3. The impact of polymorphism on prostate specific antigen gene on the risk, tumor volume and pathological stage of prostate cancer.
Chiang CH; Chen KK; Chang LS; Hong CJ
J Urol; 2004 Apr; 171(4):1529-32. PubMed ID: 15017213
[TBL] [Abstract][Full Text] [Related]
4. Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.
Nam RK; Zhang WW; Klotz LH; Trachtenberg J; Jewett MA; Sweet J; Toi A; Teahan S; Venkateswaran V; Sugar L; Loblaw A; Siminovitch K; Narod SA
Clin Cancer Res; 2006 Nov; 12(21):6452-8. PubMed ID: 17085659
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
Wang L; Habuchi T; Tsuchiya N; Mitsumori K; Ohyama C; Sato K; Kinoshita H; Kamoto T; Nakamura A; Ogawa O; Kato T
Cancer Res; 2003 Aug; 63(15):4407-11. PubMed ID: 12907612
[TBL] [Abstract][Full Text] [Related]
6. Association of codon 10 polymorphism of the transforming growth factor beta 1 gene with prostate cancer and hyperplasia in an Iranian population.
Omrani MD; Taghipour-Bazargani S; Salari-Lak S; Bagheri M
Urol Int; 2009; 83(3):329-32. PubMed ID: 19829035
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.
Li Z; Habuchi T; Tsuchiya N; Mitsumori K; Wang L; Ohyama C; Sato K; Kamoto T; Ogawa O; Kato T
Carcinogenesis; 2004 Feb; 25(2):237-40. PubMed ID: 14604900
[TBL] [Abstract][Full Text] [Related]
8. TSP1 and MMP9 genetic variants in sporadic prostate cancer.
Sfar S; Saad H; Mosbah F; Gabbouj S; Chouchane L
Cancer Genet Cytogenet; 2007 Jan; 172(1):38-44. PubMed ID: 17175378
[TBL] [Abstract][Full Text] [Related]
9. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
10. Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population?
Mittal RD; Mishra DK; Thangaraj K; Singh R; Mandhani A
Steroids; 2007 Apr; 72(4):335-41. PubMed ID: 17257635
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
[TBL] [Abstract][Full Text] [Related]
12. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
Hermans MP; Gala JL; Buysschaert M
Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism in ARE-I region of prostate-specific antigen gene associated with low serum testosterone level and high-grade prostate cancer.
Schatzl G; Marberger M; Remzi M; Grösser P; Unterlechner J; Haidinger G; Zidek T; Preyer M; Micksche M; Gsur A
Urology; 2005 Jun; 65(6):1141-5. PubMed ID: 15893813
[TBL] [Abstract][Full Text] [Related]
14. Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
Haese A; Vaisanen V; Lilja H; Kattan MW; Rittenhouse HG; Pettersson K; Chan DW; Huland H; Sokoll LJ; Partin AW
J Urol; 2005 Mar; 173(3):752-6. PubMed ID: 15711262
[TBL] [Abstract][Full Text] [Related]
15. Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome.
Sfar S; Hassen E; Saad H; Mosbah F; Chouchane L
Cytokine; 2006 Jul; 35(1-2):21-8. PubMed ID: 16908180
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta 1 gene polymorphisms and expression in the blood of prostate cancer patients.
Faria PC; Saba K; Neves AF; Cordeiro ER; Marangoni K; Freitas DG; Goulart LR
Cancer Invest; 2007 Dec; 25(8):726-32. PubMed ID: 18058470
[TBL] [Abstract][Full Text] [Related]
17. Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.
Goto T; Nakano M; Ito S; Ehara H; Yamamoto N; Deguchi T
Urology; 2007 Jul; 70(1):127-30. PubMed ID: 17656222
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in COX-2 gene influence prostate cancer susceptibility in a northern Indian cohort.
Mandal RK; Mittal RD
Arch Med Res; 2011 Oct; 42(7):620-6. PubMed ID: 22023987
[TBL] [Abstract][Full Text] [Related]
19. The association between MIF-173 G>C polymorphism and prostate cancer in southern Chinese.
Ding GX; Zhou SQ; Xu Z; Feng NH; Song NH; Wang XJ; Yang J; Zhang W; Wu HF; Hua LX
J Surg Oncol; 2009 Aug; 100(2):106-10. PubMed ID: 19475570
[TBL] [Abstract][Full Text] [Related]
20. Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population.
Patiño-García B; Arroyo C; Rangel-Villalobos H; Soto-Vega E; Velarde-Félix JS; Gabilondo F; Sandoval-Ramirez L; Figuera LE
Rev Invest Clin; 2007; 59(1):25-31. PubMed ID: 17569297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
